Clinical Trials in Fürth, Bavaria
3 recruiting
Showing 1–3 of 3 trials
Recruiting
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Breast Neoplasms
Novartis Pharmaceuticals3,250 enrolled267 locationsNCT06830720
Recruiting
Praegnant Breast Cancer: Early/Advanced/Metastatic
Breast Cancer (Early Breast Cancer)Advanced/Metastatic Breast Cancer
University Hospital Tuebingen13,500 enrolled61 locationsNCT02338167
Recruiting
Perioperative Management Evaluation in Patients With CIED
Surgery--ComplicationsCardiac Pacemaker MalfunctionICD Malfunction+2 more
Klinikum-Fuerth500 enrolled2 locationsNCT04331249